Having said that, a comparison of the safety and therapeutic effect of wild-type hASCs and human mesenchymal stem cells (hMSCs) transiently expressing CXCR4 and IL-10 was made, aiming to generate an improved anti-inflammatory response for sepsis, in addition to standard antibiotic treatment. Here, CXCR4 is linked to Sepsis.